An epidemiological study of subacute sclerosing panencephalitis in Kenya. 1983

P M Tukei, and P R Kenya, and H Ensering

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007630 Kenya A republic in eastern Africa, south of ETHIOPIA, west of SOMALIA with TANZANIA to its south, and coastline on the Indian Ocean. Its capital is Nairobi. Republic of Kenya
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D013344 Subacute Sclerosing Panencephalitis A rare, slowly progressive encephalitis caused by chronic infection with the MEASLES VIRUS. The condition occurs primarily in children and young adults, approximately 2-8 years after the initial infection. A gradual decline in intellectual abilities and behavioral alterations are followed by progressive MYOCLONUS; MUSCLE SPASTICITY; SEIZURES; DEMENTIA; autonomic dysfunction; and ATAXIA. DEATH usually occurs 1-3 years after disease onset. Pathologic features include perivascular cuffing, eosinophilic cytoplasmic inclusions, neurophagia, and fibrous gliosis. It is caused by the SSPE virus, which is a defective variant of MEASLES VIRUS. (From Adams et al., Principles of Neurology, 6th ed, pp767-8) Encephalitis, Inclusion Body, Measles,Leukoencephalitis, Subacute Sclerosing,Measles Inclusion Body Encephalitis,Panencephalitis, Subacute Sclerosing,SSPE,Van Bogaert's Leukoencephalitis,Inclusion Body Encephalitis, Measles,Leukoencephalitis, Van Bogaert's,Sclerosing Leukoencephalitis, Subacute,Sclerosing Panencephalitis, Subacute,Leukoencephalitides, Subacute Sclerosing,Leukoencephalitis, Van Bogaert,Leukoencephalitis, Van Bogaerts,Panencephalitides, Subacute Sclerosing,Sclerosing Leukoencephalitides, Subacute,Sclerosing Panencephalitides, Subacute,Subacute Sclerosing Leukoencephalitides,Subacute Sclerosing Leukoencephalitis,Subacute Sclerosing Panencephalitides,Van Bogaert Leukoencephalitis,Van Bogaerts Leukoencephalitis

Related Publications

P M Tukei, and P R Kenya, and H Ensering
February 1986, Acta neurologica Scandinavica,
P M Tukei, and P R Kenya, and H Ensering
January 1975, Transactions of the American Neurological Association,
P M Tukei, and P R Kenya, and H Ensering
November 1972, East African medical journal,
P M Tukei, and P R Kenya, and H Ensering
April 1981, Developmental medicine and child neurology,
P M Tukei, and P R Kenya, and H Ensering
March 1978, Biken journal,
P M Tukei, and P R Kenya, and H Ensering
January 1968, Neurology,
P M Tukei, and P R Kenya, and H Ensering
December 1988, Journal of tropical pediatrics,
P M Tukei, and P R Kenya, and H Ensering
July 1973, Lancet (London, England),
P M Tukei, and P R Kenya, and H Ensering
August 2001, Infection,
P M Tukei, and P R Kenya, and H Ensering
January 1976, American journal of epidemiology,
Copied contents to your clipboard!